NCT06544265
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06544265
Title SynKIR-310 for Relapsed/Refractory B-NHL
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Verismo Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute RECRUITING Denver Colorado 80218 United States Details
Winship Cancer Institute of Emory University RECRUITING Atlanta Georgia 30322 United States Details
The University of Kansas Cancer Center RECRUITING Fairway Kansas 66205 United States Details
Rutgers Cancer Institute RECRUITING New Brunswick New Jersey 08902 United States Details
Abramson Cancer Center of the University of Pennsylvania ACTIVE_NOT_RECRUITING Philadelphia Pennsylvania 19104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field